Sichenzia Ross Ference LLP Represents Sunshine Biopharma Inc. in $8 Million Underwritten Public Offering

Press Release – New York, NY – February 17, 2022 – Sichenzia Ross Ference LLP today announced that it represented Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs, in an underwritten public offering. The offering consisted of 1,882,353 units at a price to the public of $4.25 per unit. Each unit consists of one share of common stock and two warrants. The gross proceeds of the offering to the company were approximately $8 million.

Aegis Capital Corp. acted as the sole book-running manager for the offering.

The shares were issued pursuant to a Form S-1 registration statement (No. 333-259394) filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on February 14, 2022. The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Jay Yamamoto and Jeff Cahlon.

Author
Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $6.87 Million Public Offering of Common Stock of Twin Vee PowerCats Co. - October 4, 2022
Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $5.75 Million Public Offering and Nasdaq Uplisting of Silo Pharma, Inc. - October 1, 2022
Mid-Level Corporate Associate - September 29, 2022

Sichenzia Ross Ference LLP Represents Sunshine Biopharma Inc. in $8 Million Underwritten Public Offering

Related Posts